- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01353066
Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM) (EURDSS)
Multicenter Randomized Prospective Trial on the Effects of Intensive Medical Treatment of Type 2 Diabetes With and Without Roux-in-Y Gastric Bypass Surgery on Carotid Intima Media Thickness in Grade I Obesity (BMI 30,0-34,9 kg/m2)
Background: Type 2 Diabetes Mellitus (T2DM) is associated with an increased burden for cardiovascular disease (CVD). Multifactorial interventions are necessary to reduce the CV risk in T2DM. Bariatric surgery appears to be an alternative for the multifactorial intervention in T2DM associated with obesity. Data have shown, that clinical trial aiming at the control of CVRF in T2DM may not translate in the reduction of CV events.
Hypothesis: Intensive medical treatment (IMM) including Roux-en-Y Gastric Bypass (RYGBP) could be superior in the control of the progression of subclinical atherosclerotic disease, as evaluated by carotid ultrasound, in subjects with T2DM and a BMI between 30.0 and 34.9 kg/m2.The primary aim of the study is To compare the effects of intensive medical treatment (IMM) including Roux-en-Y Gastric Bypass (RYGBP) and IMM alone on the progression of the carotid intima media thickness (CIMT) at 24 months after entry into the trial relative to baseline.Methodology: Two-year Randomized Clinical Trial, including 240 patients
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Anticipado)
Fase
- Fase 2
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Catalunya
-
Barcelona, Catalunya, España, 08036
- Hospital Clínic de Barcelona
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 35 to 65 years at eligibility visit.
- Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least he six months prior to enrollment, and HbA 1c > 7.0 %.
- Current treatment for T2DM consisting of multiple doses of insulin with/without hypoglycemic agents or hypoglycemic agents plus basal insulin.
- Optimization of diabetes medical treatment prior to inclusion in the study would have been performed based on best medical practices.
- Body Mass Index (BMI)> 30.0 kg/m2 and <34.9 kg/m2 at eligibility visit.
- Willingness to accept random assignment to either treatment group.
- Expect to live or work within approximately one hour's traveling time from the study clinic for the duration of the two-year trial.
- Willingness to comply with the follow-up protocol and successful completion of the run-in.
- Written informed consent.
Exclusion Criteria:
- Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.
- Current evidence of congestive heart failure (grade II or IV), angina pectoris, symptomatic peripheral vascular disease or advanced cardiovascular disease.
- History of severe hypoglycemic episodes associated with medical treatment of type 2 DM
- Cardiac stress test indicating that surgery would not be safe
- Pulmonary embolus or thrombophlebitis in the past six months.
- Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.
- Significant anemia or history of coagulopathy.
- Serum creatinine >1.5 mg/dl.
- Serum total bilirubin or alkaline phosphatase greater than the upper limit of normal, or ALT greater than twice the upper limit of normal.
- History of previous surgery contraindicating gastric bypass at the criteria of the surgical team.
- Gastric or duodenal ulcer in the past six months.
- History of intra-abdominal sepsis (except for uncomplicated appendicitis or diverticulitis more than six months prior to enrollment).
- Previous organ transplantation.
- Self-reported HIV-positive status, active tuberculosis, active malaria, chronic hepatitis B or C, cirrhosis, or inflammatory bowel disease.
- Currently pregnant or nursing, or planning to become pregnant in the next two years.
- History of alcohol or drug dependency (excluding caffeine and nicotine) in the past five years
- Active psychosocial or psychiatric problem that is likely to interferer with adherence to the protocol.
- Score of 17 or higher on the CES-D (depression scale).
- Current participation in a conflicting research protocol.
- Presence of any chronic or debilitating disease that would make adherence to the protocol difficult.
- 12-lead EKG indicating that surgery or intensive medical treatment would not be safe.
- Diagnosed with diabetes more than 15 years ago.
- Positive GAD antibodies
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Comparador activo: Intensive Medical Treatment
|
|
Experimental: Intensive medical treatment (IMM)+RYGBP
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
Measurement of the progression carotid intima media thickness (CIMT) at 24 months after entry into the trial relative to baseline
Periodo de tiempo: 24 months
|
24 months
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- HCB-UOM-012011
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Enfermedad cardiovascular aterosclerótica
-
Mayo ClinicInscripción por invitaciónRiesgo cardiovascular | Prevención cardiovascularEstados Unidos
-
University of DelawareReclutamientoFactor de riesgo cardiovascular | Salud cardiovascularEstados Unidos
-
Oregon Health and Science UniversityTerminadoEnfermedad cardiovascular | Factores de riesgo cardiovascularEstados Unidos
-
Medical College of WisconsinReclutamientoEnfermedades cardiovasculares | Factor de riesgo cardiovascular | Salud cardiovascularEstados Unidos
-
Hospital Mutua de TerrassaTerminadoEnfermedad cardiovascular | Factor de riesgo cardiovascularEspaña
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityTerminadoEnfermedad cardiovascular | Influencia psicosocial en la enfermedad cardiovascularEstados Unidos
-
Medical College of WisconsinTerminadoEnfermedades cardiovasculares | Factores de riesgo cardiovascular | Salud cardiovascular | Impacto del cantoEstados Unidos
-
Centre Hospitalier Universitaire DijonTerminadoPacientes de Alto Riesgo Cardiovascular | Pacientes de bajo riesgo cardiovascularFrancia
-
Shanghai 10th People's HospitalDesconocidoPresión arterial | Factor de riesgo cardiovascular | Mortalidad global | Mortalidad cardiovascular | Eventos cardiovasculares | Daño al órgano dianaPorcelana
-
Methodist Health SystemTerminado
Ensayos clínicos sobre Intensive Medical Treatment
-
University of OklahomaTerminadoAumento de peso | Trastorno de alimentación Neonatal | Lactante de muy bajo peso al nacerEstados Unidos
-
Abbott Medical DevicesTerminado
-
Abbott Medical DevicesTerminado
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke... y otros colaboradoresTerminado
-
General University Hospital, PragueReclutamiento
-
University of Nove de JulhoMulti Radiance MedicalReclutamientoDolor de rodilla crónicoBrasil
-
Soterix MedicalNYU Langone HealthTerminadoDepresión resistente al tratamiento | Depresión unipolarEstados Unidos
-
Allenmore HospitalTerminadoCuidado PostoperatorioEstados Unidos
-
H. Lee Moffitt Cancer Center and Research InstituteReclutamientoHiperplasia prostática benigna | Carcinoma de próstataEstados Unidos
-
University of Alabama at BirminghamInscripción por invitaciónProlapso de órganos pélvicosEstados Unidos